No biomarker	Diffuse Large B Cell Lymphoma	No biomarker	Diffuse Large B Cell Lymphoma	FT516 Sensitive: B - Late Trials FT516 Sensitive : B	FT516 Sensitive: B - Late Trials FT516 Sensitive : B
No biomarker	Hematological Malignancies	No biomarker	Hematological Malignancies	IPH6101 Sensitive: B - Late Trials IPH6101 Sensitive : B	IPH6101 Sensitive: B - Late Trials IPH6101 Sensitive : B
CD276 overexpression	Solid Tumor	CD276 overexpression	Solid Tumor	GTB-5550 Sensitive: D – Preclinical GTB-5550 Sensitive : D	GTB-5550 Sensitive: D – Preclinical GTB-5550 Sensitive : D

CD16 agonist

Associations(3)